Data / Form D filings / Bridge Therapeutics, Inc.
Bridge Therapeutics, Inc.: Form D filings
Bridge Therapeutics, Inc., a pharmaceuticals company in Birmingham, AL, filed 5 Form D notices with the SEC between 2018 and 2023. The latest, on December 18, 2023, reports $321,000 sold of a $1.5 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 217 COUNTRY CLUB PARK, STE, SUITE 325, Birmingham, AL, 35213
- Phone
- (800) 223-6949
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1724287
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | New notice | $1,500,000 | $321,000 | $1,179,000 | 22 | Oct 27, 2023 | sec.gov |
| Apr 24, 2019 | Amendment | Indefinite | $2,000,000 | 11 | Apr 8, 2019 | sec.gov | |
| Mar 8, 2019 | Amendment | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Feb 23, 2018 | Amendment | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Feb 22, 2018 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Patrick Palutis | Director | |
| Joseph Patrick Mullin | Director | |
| Elizabeth Gregory Kelley | Director | |
| Jason Patrick Bailey | Director | |
| Timothy Grant Peara | Executive Officer | |
| James Gregory Sullivan | Executive Officer, Director |
Every Form D from the week of Dec 18, 2023 · All recent filings in Alabama · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Bridge Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.